Verona Pharma PLC ADR
Biotechnology
Healthcare
VRNA
81.49 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
52.77
52 week high
69.63
high
58.42
52 week low
12.13
low
47.81
growth
379.78 %
previous Close
54.17
P/E ratio
market cap
3.69 B
div yield
0
net incoming
-42.96 M
39.42 %
net profit margin
-763.90 %
-763.00 %
operating incoming
-40.67 M
40.63 %
net change in cash
-68.56 M
-145.79 %
cash on hand
336 M
-16.94 %
cost of revenue
543 K
100.89 %
top